TREA

Method and apparatus for reducing early recurrence of atrial fibrillation with defibrillation shock therapy

Follow

Information

  • Patent Grant
  • 6847842
  • Patent Number
    6,847,842
  • Date Filed
    Monday, May 15, 2000
    24 years ago
  • Date Issued
    Tuesday, January 25, 2005
    20 years ago
Information
Abstract
An apparatus and method for delivering electrical shock therapy in order to treat atrial tachyarrhythmias such as fibrillation in which atrial defibrillation pulses are delivered within a maximum pre-shock R—R synchronization interval. The method has been found to reduce the incidence of early recurrence of atrial fibrillation (ERAF).
Description
FIELD OF THE INVENTION

This invention pertains to methods for treating atrial tachyarrhythmias. In particular, the invention relates to an apparatus and method for delivering shock therapy to terminate atrial fibrillation.


BACKGROUND

Tachyarrhythmias are abnormal heart rhythms characterized by a rapid heart rate, typically expressed in units of beats per minute (bpm). They can occur in either chamber of the heart (i.e., ventricles or atria) or both. Examples of tachyarrhythmias include sinus tachycardia, ventricular tachycardia, ventricular fibrillation (VF), atrial tachycardia, and atrial fibrillation (AF). Tachycardia is characterized by a rapid rate, either due to an ectopic excitatory focus or abnormal excitation by normal pacemaker tissue. Fibrillation occurs when the chamber depolarizes in a chaotic fashion with abnormal depolarization waveforms as reflected by an EKG.


An electrical shock applied to a heart chamber (i.e., defibrillation or cardioversion) can be used to terminate most tachyarrhythmias by depolarizing excitable myocardium, which thereby prolongs refractoriness, interrupts reentrant circuits, and discharges excitatory foci. Implantable cardioverter/defibrillators (ICDs) provide this kind of therapy by delivering a shock pulse to the heart when fibrillation is detected by the device. An ICD is a computerized device containing a pulse generator that is usually implanted into the chest or abdominal wall. Electrodes connected by leads to the ICD are placed on the heart, or passed transvenously into the heart, to sense cardiac activity and to conduct the shock pulses from the pulse generator. ICDs can be designed to treat either atrial or ventricular tachyarrhythmias, or both, and also incorporate cardiac pacing functionality.


The most dangerous tachyarrythmias are ventricular tachycardia and ventricular fibrillation, and ICDs have most commonly been applied in the treatment of those conditions. ICDs are also capable, however, of detecting atrial fibrillation and delivering a shock pulse to the atria in order to terminate the arrhythmia. Although not immediately life-threatening, it is important to treat atrial fibrillation for several reasons. First, atrial fibrillation is associated with a loss of atrio-ventricular synchrony which can be hemodynamically compromising and cause such symptoms as dyspnea, fatigue, vertigo, and angina. Atrial fibrillation can also predispose to strokes resulting from emboli forming in the left atrium. Although drug therapy and/or in-hospital cardioversion are acceptable treatment modalities for atrial fibrillation, ICDs configured to treat AF offer a number of advantages to certain patients, including convenience and greater efficacy.


An ICD terminates atrial fibrillation by delivering a shock pulse to electrodes disposed in or near the atria. The resulting depolarization also spreads to the ventricles, however, and there is a risk that such an atrial shock pulse can actually induce ventricular fibrillation, a condition much worse than atrial fibrillation. This risk can be reduced by delaying the delivery of an atrial shock pulse until the intrinsic ventricular rhythm is below a specified maximum rate and then delivering the shock synchronously with a sensed ventricular depolarization.


Another problem associated with defibrillation shock therapy is early recurrence of atrial fibrillation or ERAF. ERAF is defined as the recurrence of atrial fibrillation within a few minutes after successful cardioversion with atrial shock therapy. Certain patients are more prone than others to experience ERAF, and these patients may experience difficulty with repeated atrial defibrillation therapy. Reducing the incidence of ERAF would improve the efficacy of atrial defibrillation and expand the population of patients for whom an ICD is an acceptable therapy option. It is this problem with which the present invention is primarily concerned.


SUMMARY OF THE INVENTION

The present invention is a method and apparatus for delivering atrial defibrillation therapy in which an atrial shock pulse is delivered within a specified maximum time interval after a preceding sensed ventricular depolarization or ventricular pace (R wave). In one embodiment, an R—R interval, defined as the time elapsed between a previous R wave and a present R wave, is measured after each sensed R wave. The atrial defibrillation shock pulse is then delivered synchronously with an R wave that occurs within a specified time window with respect to the previous R wave as defined by specified minimum and maximum R—R interval values. In another embodiment, an atrial shock pulse is delivered at a specified time after the previous R wave unless inhibited by an intrinsic ventricular depolarization occurring before the specified time. The atrial defibrillation shock can also be delivered in synchrony with a ventricular pace delivered at a specified time after the previous R wave unless inhibited by an R wave occurring before that time.


In one embodiment, an R—R interval, defined as the time elapsed between a previous R wave and a present R wave, is measured after each sensed R wave. The atrial defibrillation shock pulse is then delivered synchronously with an R wave that occurs within a specified time window with respect to the previous R wave as defined by specified minimum and maximum R—R interval values. In another embodiment, an atrial shock pulse delivered at a specified time after the previous R wave unless inhibited by an intrinsic ventricular depolarization occurring before the specified time. The atrial defibrillation shock can also be delivered in synchrony with a ventricular pace delivered at a specified time after the previous R wave unless inhibited by an R wave occurring before that time.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A and 1B are timing diagrams illustrating embodiments of the invention.



FIG. 2 is a system diagram of an implantable defibrillator.





DETAILED DESCRIPTION OF THE INVENTION

The present invention is a method and apparatus for delivering atrial defibrillation shock therapy. As used herein, atrial defibrillation shock therapy should be taken to mean shock therapy for treating any atrial tachyarrhythmia, such as atrial flutter, as well as atrial fibrillation.


In order to avoid the possible induction of ventricular fibrillation, atrial defibrillation shocks are usually delivered synchronously with a sensed R wave and after a minimum pre-shock R—R interval. (The R—R interval is the time between the immediately preceding R wave and the presently sensed R wave, and an R wave may be regarded as either a spontaneously occurring depolarization or a ventricular pace.) This is done because the ventricle is especially vulnerable to induction of fibrillation by a depolarizing shock delivered at a time too near the end of the preceding ventricular contraction (i.e., close to the T wave on an EKG). Delivering the shock synchronously with a sensed R wave thus moves the shock away from the vulnerable period, but at a very rapid ventricular rhythm, the ventricular beats may be so close together that even synchronously delivered shocks may induce ventricular fibrillation. To prevent this, shocking can be delayed until the ventricular rhythm is slow enough to safely deliver the defibrillation pulse as determined by measuring the R—R interval. That is, a minimum limit value for the R—R interval is specified, and shocking is inhibited if the sensed R wave occurs after a shorter interval. Recent clinical data has shown, however, that the incidence of early recurrence of atrial fibrillation (ERAF) after atrial defibrillation is positively correlated with the length of the pre-shock R—R interval.


In accordance with the present invention, atrial defibrillation shocks are delivered within a specified maximum time interval after a preceding sensed ventricular depolarization or ventricular pace (R wave). In one embodiment, the atrial defibrillation shock is delivered in synchrony with a sensed R wave. An R—R interval, defined as the time elapsed between a previous R wave and a present R wave, is measured after each sensed R wave. In contradistinction to previous methods, however, a shockable R—R interval is specified with both minimum and maximum limit values. The atrial defibrillation shock pulse is thus delivered synchronously with an R wave that occurs within a time window with respect to the previous R wave as defined by specified minimum and maximum R—R interval values. FIG. 1A is a diagram showing a sequence of intrinsic ventricular depolarizations IVD occurring during an episode of atrial defibrillation. After the depolarization labeled IVD1, a time window TW as defined by a minimum R—R interval MIN and a maximum R—R interval MAX is shown. This time window is considered a shockable R—R interval, and exemplary minimum and maximum limit values are 500 and 800 milliseconds, respectively. Thus, an atrial defibrillation shock ADF can be delivered in synchrony with an R wave IVD2 occurring within the shockable interval and with a reduced risk of causing either ventricular fibrillation or ERAF.


In another embodiment, an atrial shock pulse is delivered at a specified time after the previous R wave unless inhibited by an intrinsic ventricular depolarization occurring before the specified time. FIG. 1B shows another exemplary sequence of intrinsic ventricular depolarizations IVD occurring during an episode of atrial defibrillation. After the depolarization labeled IVD1, a specified time T1 is defined in which an atrial defibrillation shock ADF is to be delivered. The time T1 would preferably fall somewhere within the shockable R—R interval as defined above even though the atrial shock is not delivered in synchrony with an R wave. Delivering the atrial shock pulse at the time T1 thus reduces the risk of ERAF as in the first embodiment. Induction of ventricular fibrillation is prevented by both specifying the time T1 to be above a minimum value considered safe to shock and inhibiting the atrial shock if an intrinsic R wave occurs prior to the time T1. The atrial defibrillation shock can also be delivered in synchrony with a ventricular pace delivered at the specified time T1 after the previous R wave unless inhibited by an R wave occurring before that time.



FIG. 2 is a system diagram of a microprocessor-based implantable cardioverter/defibrillator device for treating atrial tachyarrthmias that also incorporates a pacemaker functionality. In this embodiment, a microprocessor and associated circuitry make up the controller of the device, enabling it to output pacing or shock pulses in response to sensed events and lapsed time intervals. The microprocessor 10 communicates with a memory 12 via a bidirectional data bus. The memory 12 typically comprises a ROM or RAM for program storage and a RAM for data storage. The ICD has atrial sensing and pacing channels comprising electrode 34, lead 33, sensing amplifier 31, pulse generator 32, and an atrial channel interface 30 which communicates bidirectionally with a port of microprocessor 10. The ventricular sensing and pacing channels similarly comprise electrode 24, lead 23, sensing amplifier 21, pulse generator 22, and a ventricular channel interface 20. For each channel, the same lead and electrode are used for both sensing and pacing. The sensing channels are used to control pacing and for measuring heart rate in order to detect tachyarrythmias such as fibrillation. The ICD detects an atrial tachyarrhythmia, for example, by measuring the atrial rate as well as possibly performing other processing on data received from the atrial sensing channel. A shock pulse generator 50 is interfaced to the microprocessor for delivering shock pulses to the atrium via a pair of terminals 51a and 51b that are connected by defibrillation leads to shock electrodes placed in proximity to regions of the heart. The defibrillation leads have along their length electrically conductive coils that act as electrodes for defibrillation stimuli. A similar shock pulse generator 60 and shock electrodes 61a and 61b are provided to deliver ventricular fibrillation therapy in the event of an induced ventricular fibrillation from atrial shock pulses.


The device depicted in FIG. 2 can be configured to deliver atrial defibrillation therapy in accordance with the invention as described above by appropriate programming of the microprocessor. Thus, once an episode of atrial fibrillation is detected with the atrial sensing channel, the device prepares to deliver an atrial defibrillation shock. As described above, the ventricular rhythm can monitored by measuring the R—R interval associated with each sensed R wave. If a sensed R wave occurs at an R—R interval longer than a specified minimum limit value and shorter than a specified maximum limit value, the interval is considered shockable so that the sensed R wave is safe to shock on. An atrial defibrillation shock can then delivered immediately so as to be practically synchronous with the sensed R wave. Alternatively, the atrial shock pulse can be delivered at a specified time after the preceding sensed R wave, either synchronously with a ventricular pace or not, unless inhibited by a sensed intrinsic R wave occurring prior to the time specified for delivering the atrial shock.


In another embodiment of the invention, an atrial defibrillation shock pulse is preceded by ventricular pacing in order to decrease the intrinsic ventricular rhythm to a rate at which the atrial defibrillation shock pulse can be more safely delivered. After atrial fibrillation is detected, a sequence of one or more ventricular pacing pulses is delivered at a rate intended to be above the intrinsic ventricular rate. After the last pacing pulse in the sequence is delivered, a compensatory pause is produced before the next intrinsic ventricular beat. The atrial defibrillation shock pulse can then be delivered synchronously with that beat if the sensed R wave occurs within the shockable R—R interval as defined by specified minimum and maximum limit value. In the embodiment where the atrial defibrillation pulse is to be delivered at a specified time after the preceding R wave, either with or without an accompanying ventricular pace, the compensatory pause also delays the next R wave so that inhibition of the atrial shock is less likely to occur.


Although the invention has been described in conjunction with the foregoing specific embodiment, many alternatives, variations, and modifications will be apparent to those of ordinary skill in the art. Such alternatives, variations, and modifications are intended to fall within the scope of the following appended claims.

Claims
  • 1. A method for delivering atrial defibrillation therapy, comprising: detecting an episode of atrial fibrillation; sensing ventricular depolarizations (R waves); delivering a first ventricular pacing pulse after a sensed R wave; and delivering an atrial defibrillation shock without an accompanying second ventricular pacing pulse at a specified time after the first ventricular pacing pulse but inhibiting the atrial defibrillation shock if a second R wave subsequent to the first ventricular pacing pulse occurs before the specified time.
  • 2. The method of claim 1 wherein the specified time for delivering the atrial defibrillation shock is less than 800 milliseconds.
  • 3. The method of claim 1 wherein the specified time for delivering the atrial defibrillation shock is greater than 500 milliseconds and less than 800 milliseconds.
  • 4. The method of claim 1 wherein the first ventricular pacing pulse is preceded by one or more additional ventricular pacing pulses delivered after the sensed R wave at a rate greater than the measured intrinsic rate.
  • 5. The method of claim 1 wherein the specified time for delivering the atrial defibrillation shock is less than 800 milliseconds.
  • 6. The method of claim 5 wherein the specified time for delivering the atrial defibrillation shock is greater than 500 milliseconds and less than 800 milliseconds.
  • 7. The method of claim 1 wherein the first ventricular pacing pulse is delivered after the sensed R wave at a rate above an intrinsic ventricular rate.
  • 8. An apparatus for delivering atrial defibrillation therapy to an atrium, comprising: sensing channels for sensing atrial and ventricular depolarizations (R waves); a ventricular pacing channel for delivering ventricular pacing pulses; an atrial defibrillation pulse generator and electrodes disposed in proximity to the atrium; and a controller for detecting atrial fibrillation and for controlling delivery of atrial defibrillation shocks and ventricular pacing pulses, wherein, upon detection of atrial fibrillation, the controller is configured to: deliver a first ventricular pacing pulse after a sensed R wave; and deliver an atrial defibrillation shock without an accompanying second ventricular pacing pulse at a specified time after the first ventricular pacing pulse but inhibit the atrial defibrillation shock if an R wave subsequent to the first ventricular pacing pulse occurs before the specified time.
  • 9. The apparatus of claim 8 wherein the specified time for delivering the atrial defibrillation shock is less than 800 milliseconds.
  • 10. The apparatus of claim 8 wherein the specified time for delivering the atrial defibrillation shock is greater than 500 milliseconds and less than 800 milliseconds.
  • 11. The apparatus of claim 8 wherein the controller is configured to deliver the first ventricular pacing pulse preceded by one or more additional ventricular pacing pulses delivered after the sensed R wave at a rate greater than the measured intrinsic rate.
  • 12. The apparatus of claim 8 wherein the first ventricular pacing pulse is delivered after the sensed R wave at a rate above an intrinsic ventricular rate.
US Referenced Citations (191)
Number Name Date Kind
3937226 Funke Feb 1976 A
4202340 Langer et al. May 1980 A
RE30387 Denniston, III et al. Aug 1980 E
4378020 Nappholz et al. Mar 1983 A
4407288 Langer et al. Oct 1983 A
4488561 Doring Dec 1984 A
4523593 Rueter Jun 1985 A
4548203 Tacker, Jr. et al. Oct 1985 A
4554922 Prystowsky et al. Nov 1985 A
4559946 Mower Dec 1985 A
4595009 Leinders Jun 1986 A
4637397 Jones et al. Jan 1987 A
4641656 Smits Feb 1987 A
4662382 Sluetz et al. May 1987 A
4665919 Mensink et al. May 1987 A
4693253 Adams Sep 1987 A
4708145 Tacker, Jr. et al. Nov 1987 A
4763646 Lekholm Aug 1988 A
4774952 Smits Oct 1988 A
4775950 Terada et al. Oct 1988 A
4787389 Tarjan Nov 1988 A
4788980 Mann et al. Dec 1988 A
4800883 Winstrom Jan 1989 A
4819643 Menken Apr 1989 A
4821723 Baker, Jr. et al. Apr 1989 A
4821724 Whigham et al. Apr 1989 A
4827932 Ideker et al. May 1989 A
4834100 Charms May 1989 A
4880004 Baker, Jr. et al. Nov 1989 A
4903700 Whigham et al. Feb 1990 A
4940054 Grevis et al. Jul 1990 A
4944300 Saksena Jul 1990 A
4949719 Pless et al. Aug 1990 A
4951667 Markowitz et al. Aug 1990 A
4967747 Carroll et al. Nov 1990 A
4972835 Carroll et al. Nov 1990 A
4984572 Cohen Jan 1991 A
4996984 Sweeney Mar 1991 A
5007422 Pless et al. Apr 1991 A
5018523 Bach, Jr. et al. May 1991 A
5042480 Hedin et al. Aug 1991 A
5048521 Pless et al. Sep 1991 A
5077667 Brown et al. Dec 1991 A
5085213 Cohen Feb 1992 A
5103819 Baker et al. Apr 1992 A
5111811 Smits May 1992 A
5111812 Swanson et al. May 1992 A
5117824 Keimel et al. Jun 1992 A
5154485 Fleishman Oct 1992 A
5161527 Nappholz et al. Nov 1992 A
5161528 Sweeney Nov 1992 A
5163428 Pless Nov 1992 A
5165403 Mehra Nov 1992 A
5178140 Ibrahim Jan 1993 A
5179945 Van Hofwegen et al. Jan 1993 A
5188105 Keimel Feb 1993 A
5193535 Bardy et al. Mar 1993 A
5193536 Mehra Mar 1993 A
5205283 Olson Apr 1993 A
5207219 Adams et al. May 1993 A
5265600 Adams et al. Nov 1993 A
5269300 Kelly et al. Dec 1993 A
5275621 Mehra Jan 1994 A
5277231 Dostalek Jan 1994 A
5282836 Kreyenhagen et al. Feb 1994 A
5282838 Hauser et al. Feb 1994 A
5285780 Tsuji et al. Feb 1994 A
5314448 Kroll et al. May 1994 A
5330508 Gunderson Jul 1994 A
5332400 Alferness Jul 1994 A
5339820 Henry et al. Aug 1994 A
5346506 Mower et al. Sep 1994 A
5350401 Levine Sep 1994 A
5354316 Keimel Oct 1994 A
5366485 Kroll et al. Nov 1994 A
5370124 Dissing et al. Dec 1994 A
5370667 Alt Dec 1994 A
5374282 Nichols et al. Dec 1994 A
5376103 Anderson et al. Dec 1994 A
5383907 Kroll Jan 1995 A
5395373 Ayers Mar 1995 A
5396902 Brennen et al. Mar 1995 A
5403355 Alt Apr 1995 A
5403356 Hill et al. Apr 1995 A
5411524 Rahul May 1995 A
5431682 Hedberg Jul 1995 A
5431685 Alt Jul 1995 A
5439006 Brennen et al. Aug 1995 A
5439483 Duong-Van Aug 1995 A
5441518 Adams et al. Aug 1995 A
5441521 Hedberg Aug 1995 A
5456706 Pless et al. Oct 1995 A
5458622 Alt Oct 1995 A
5464429 Hedberg et al. Nov 1995 A
5466245 Spinelli et al. Nov 1995 A
5476498 Ayers Dec 1995 A
5476499 Hirschberg Dec 1995 A
5480413 Greenhut et al. Jan 1996 A
5486198 Ayers et al. Jan 1996 A
5489293 Pless et al. Feb 1996 A
5500008 Fain Mar 1996 A
5507780 Finch Apr 1996 A
5522853 Kroll Jun 1996 A
5545182 Stotts et al. Aug 1996 A
5545204 Cammilli et al. Aug 1996 A
5549642 Min et al. Aug 1996 A
5554174 Causey, III Sep 1996 A
5560370 Verrier et al. Oct 1996 A
5562709 White Oct 1996 A
5584864 White Dec 1996 A
5591215 Greenhut et al. Jan 1997 A
5609613 Woodson et al. Mar 1997 A
5609621 Bonner Mar 1997 A
5617854 Munsif Apr 1997 A
5620468 Mongeon et al. Apr 1997 A
5620469 Kroll Apr 1997 A
5626136 Webster, Jr. May 1997 A
5628778 Kruse et al. May 1997 A
5662119 Brennen et al. Sep 1997 A
5662687 Hedberg et al. Sep 1997 A
5674250 de Coriolis et al. Oct 1997 A
5683431 Wang Nov 1997 A
5683445 Swoyer Nov 1997 A
5690686 Min et al. Nov 1997 A
5699014 Haefner et al. Dec 1997 A
5709215 Perttu et al. Jan 1998 A
5713924 Min et al. Feb 1998 A
5759202 Schroeppel Jun 1998 A
5772590 Webster, Jr. Jun 1998 A
5772693 Brownlee Jun 1998 A
5776164 Ripart Jul 1998 A
5778881 Sun et al. Jul 1998 A
5782239 Webster, Jr. Jul 1998 A
5782887 van Krieken et al. Jul 1998 A
5797967 KenKnight Aug 1998 A
5814081 Ayers et al. Sep 1998 A
5824031 Cookston et al. Oct 1998 A
5840079 Warman et al. Nov 1998 A
5843153 Johnston et al. Dec 1998 A
5849032 Van Venrooij Dec 1998 A
5853426 Shieh Dec 1998 A
5865838 Obel et al. Feb 1999 A
5868680 Steiner et al. Feb 1999 A
5873842 Brennen et al. Feb 1999 A
5893882 Peterson et al. Apr 1999 A
5902331 Bonner et al. May 1999 A
5922014 Warman et al. Jul 1999 A
5925073 Chastain et al. Jul 1999 A
5951471 de la Rama et al. Sep 1999 A
5955218 Crespi et al. Sep 1999 A
5964795 McVenes et al. Oct 1999 A
5968079 Warman et al. Oct 1999 A
5987354 Cooper et al. Nov 1999 A
5991657 Kim Nov 1999 A
5999850 Dawson et al. Dec 1999 A
5999854 Deno et al. Dec 1999 A
5999858 Sommer et al. Dec 1999 A
6006122 Smits Dec 1999 A
6006137 Williams Dec 1999 A
6021354 Warman et al. Feb 2000 A
6047210 Kim et al. Apr 2000 A
6055457 Bonner Apr 2000 A
6067471 Warren May 2000 A
6070104 Hine et al. May 2000 A
6076014 Alt Jun 2000 A
6081745 Mehra Jun 2000 A
6081746 Pendekanti et al. Jun 2000 A
RE36765 Mehra Jul 2000 E
6085116 Pendekanti et al. Jul 2000 A
6085119 Scheiner et al. Jul 2000 A
6091988 Warman et al. Jul 2000 A
6115628 Stadler et al. Sep 2000 A
6115630 Stadler et al. Sep 2000 A
6161037 Cohen Dec 2000 A
6246906 Hsu et al. Jun 2001 B1
6249699 Kim Jun 2001 B1
6256534 Dahl Jul 2001 B1
6272380 Warman et al. Aug 2001 B1
6275734 McClure et al. Aug 2001 B1
6280391 Olson et al. Aug 2001 B1
6430438 Chen et al. Aug 2002 B1
6430449 Hsu et al. Aug 2002 B1
6459932 Mehra Oct 2002 B1
6526317 Hsu et al. Feb 2003 B2
6556862 Hsu et al. Apr 2003 B2
6584350 Kim et al. Jun 2003 B2
6587720 Hsu et al. Jul 2003 B2
6721596 Girouard et al. Apr 2004 B1
20030004551 Chen Jan 2003 A1
20030199928 Hsu et al. Oct 2003 A1
20040015192 Kim et al. Jan 2004 A1
Foreign Referenced Citations (20)
Number Date Country
0347708 Dec 1989 EP
0436517 Jul 1991 EP
0467652 Jan 1992 EP
0522693 Jan 1993 EP
0550343 Jul 1993 EP
0550344 Jul 1993 EP
0588125 Sep 1993 EP
0588124 Mar 1994 EP
0594269 Apr 1994 EP
0606688 Jul 1994 EP
0770412 May 1997 EP
0813886 Dec 1997 EP
2528708 Dec 1983 FR
WO-9302746 Feb 1993 WO
WO-9320888 Oct 1993 WO
WO-9528987 Nov 1995 WO
WO-9528988 Nov 1995 WO
WO-WO9701373 Jan 1997 WO
WO-9701373 Jan 1997 WO
WO-9848891 Nov 1998 WO